These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 15628299

  • 41. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
    Zhang H, Pelzer AM, Kiang DT, Yee D.
    Cancer Res; 2007 Jan 01; 67(1):391-7. PubMed ID: 17210722
    [Abstract] [Full Text] [Related]

  • 42. Effects of hyperglycemia on the differential expression of insulin and insulin-like growth factor-I receptors in human normal peritoneal and adhesion fibroblasts.
    Rizk NN, Saed GM, Diamond MP.
    Fertil Steril; 2006 Oct 01; 86(4 Suppl):1217-22. PubMed ID: 16962112
    [Abstract] [Full Text] [Related]

  • 43. Supplementation with branched-chain amino acids inhibits azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.
    Shimizu M, Shirakami Y, Iwasa J, Shiraki M, Yasuda Y, Hata K, Hirose Y, Tsurumi H, Tanaka T, Moriwaki H.
    Clin Cancer Res; 2009 May 01; 15(9):3068-75. PubMed ID: 19366832
    [Abstract] [Full Text] [Related]

  • 44. Expression and growth dependency of the insulin-like growth factor I receptor in craniopharyngioma cells: a novel therapeutic approach.
    Ulfarsson E, Karström A, Yin S, Girnita A, Vasilcanu D, Thoren M, Kratz G, Hillman J, Axelson M, Larsson O, Girnita L.
    Clin Cancer Res; 2005 Jul 01; 11(13):4674-80. PubMed ID: 16000560
    [Abstract] [Full Text] [Related]

  • 45. Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells.
    Youngren JF, Gable K, Penaranda C, Maddux BA, Zavodovskaya M, Lobo M, Campbell M, Kerner J, Goldfine ID.
    Breast Cancer Res Treat; 2005 Nov 01; 94(1):37-46. PubMed ID: 16142439
    [Abstract] [Full Text] [Related]

  • 46. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
    Jernberg-Wiklund H, Nilsson K.
    Adv Cancer Res; 2007 Nov 01; 97():139-65. PubMed ID: 17419944
    [Abstract] [Full Text] [Related]

  • 47. Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation.
    Jones RA, Campbell CI, Gunther EJ, Chodosh LA, Petrik JJ, Khokha R, Moorehead RA.
    Oncogene; 2007 Mar 08; 26(11):1636-44. PubMed ID: 16953219
    [Abstract] [Full Text] [Related]

  • 48. Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium.
    Sutherland BW, Knoblaugh SE, Kaplan-Lefko PJ, Wang F, Holzenberger M, Greenberg NM.
    Cancer Res; 2008 May 01; 68(9):3495-504. PubMed ID: 18451178
    [Abstract] [Full Text] [Related]

  • 49. Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors.
    Molinolo AA, Lanari C, Charreau EH, Sanjuan N, Pasqualini CD.
    J Natl Cancer Inst; 1987 Dec 01; 79(6):1341-50. PubMed ID: 2826865
    [Abstract] [Full Text] [Related]

  • 50. Involvement of insulin-like growth factors-I and -II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas.
    Elizalde PV, Lanari C, Molinolo AA, Guerra FK, Balañá ME, Simian M, Iribarren AM, Charreau EH.
    J Steroid Biochem Mol Biol; 1998 Nov 01; 67(4):305-17. PubMed ID: 9883987
    [Abstract] [Full Text] [Related]

  • 51. Enhanced expression of angiotensin II receptor subtypes and angiotensin converting enzyme in medroxyprogesterone-induced mouse mammary adenocarcinomas.
    Guerra FK, Ciuffo GM, Elizalde PV, Charreau EH, Saavedra JM.
    Biochem Biophys Res Commun; 1993 May 28; 193(1):93-9. PubMed ID: 8389152
    [Abstract] [Full Text] [Related]

  • 52. Enhanced therapeutic effects for human pancreatic cancer by application K-ras and IGF-IR antisense oligodeoxynucleotides.
    Shen YM, Yang XC, Yang C, Shen JK.
    World J Gastroenterol; 2008 Sep 07; 14(33):5176-85. PubMed ID: 18777594
    [Abstract] [Full Text] [Related]

  • 53. Optimization of antisense drug design against conservative local motif in simulant secondary structures of HER-2 mRNA and QSAR analysis.
    Yang SP, Song ST, Tang ZM, Song HF.
    Acta Pharmacol Sin; 2003 Sep 07; 24(9):897-902. PubMed ID: 12956938
    [Abstract] [Full Text] [Related]

  • 54. Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas.
    Andrews DW, Resnicoff M, Flanders AE, Kenyon L, Curtis M, Merli G, Baserga R, Iliakis G, Aiken RD.
    J Clin Oncol; 2001 Apr 15; 19(8):2189-200. PubMed ID: 11304771
    [Abstract] [Full Text] [Related]

  • 55. Demonstration of tumor suppression by mannose 6-phosphate/insulin-like growth factor 2 receptor.
    Li J, Sahagian GG.
    Oncogene; 2004 Dec 16; 23(58):9359-68. PubMed ID: 15543235
    [Abstract] [Full Text] [Related]

  • 56. Antisense phosphorothioate oligodeoxynucleotide down-regulation of the insulin-like growth factor I receptor in ovarian cancer cells.
    Müller M, Dietel M, Turzynski A, Wiechen K.
    Int J Cancer; 1998 Aug 12; 77(4):567-71. PubMed ID: 9679760
    [Abstract] [Full Text] [Related]

  • 57. Antisense inhibition of IGF receptor expression in HaCaT keratinocytes: a model for antisense strategies in keratinocytes.
    White PJ, Fogarty RD, Werther GA, Wraight CJ.
    Antisense Nucleic Acid Drug Dev; 2000 Jun 12; 10(3):195-203. PubMed ID: 10905556
    [Abstract] [Full Text] [Related]

  • 58. Inhibition of hepatocellular carcinoma growth by antisense oligonucleotides to type I insulin-like growth factor receptor in vitro and in an orthotopic model.
    Lin RX, Wang ZY, Zhang N, Tuo CW, Liang QD, Sun YN, Wang SQ.
    Hepatol Res; 2007 May 12; 37(5):366-75. PubMed ID: 17441810
    [Abstract] [Full Text] [Related]

  • 59. Small interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer model.
    Durfort T, Tkach M, Meschaninova MI, Rivas MA, Elizalde PV, Venyaminova AG, Schillaci R, François JC.
    PLoS One; 2012 May 12; 7(1):e29213. PubMed ID: 22235273
    [Abstract] [Full Text] [Related]

  • 60. [Inhibitory effect of antisense oligodeoxynucleotides targeting HER-2 mRNA on growth of breast cancer: experiment in vivo with mice].
    Sun JZ, Song HF, Li LS, Song ST, Zhu JH, Zhao H.
    Zhonghua Yi Xue Za Zhi; 2006 Feb 28; 86(8):540-3. PubMed ID: 16681883
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.